Replies to post #156531 on Biotech Values

[mcbio]

I listened to the CC, but I wasn't sure what the CFO said about the burn rate. Are you concerned that with all these dates being pushed back that there will be a need for another financing fairly soon.

I don't think so, but that's always hard to predict. I think ARRY still believes they will ink at least one deal this year for some non-dilutive capital, I'm just less certain that it will be ARRY-797.

On 520, my sense was that ARRY wants to partner the drug throughout the world.

I didn't get that sense at all.

Squarer didn't seem too positive about a partnership for 797.

Agreed.